• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参与强直性脊柱炎发病机制的免疫细胞。

Immune cells involved in the pathogenesis of ankylosing spondylitis.

机构信息

Department of Immunology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Biomed Pharmacother. 2018 Apr;100:198-204. doi: 10.1016/j.biopha.2018.01.108. Epub 2018 Feb 16.

DOI:10.1016/j.biopha.2018.01.108
PMID:29428668
Abstract

Ankylosing spondylitis (AS) is an inflammatory autoimmune disease. AS is a prototype form of spondyloarthropathies (SpA). The precise etiology of AS has not been fully understood. But Inflammation has a critical role in the pathogenesis of the disease. The immune system by various cells, secreted-mediators and markers manage and regulate the immune responses and inflammation. Every factor which disturbed this regulation and hemostasis can cause chronic inflammation. In this review, we discussed the role of several innate and adaptive immune cells involved in the triggering, initiation, development, and regulation of AS.

摘要

强直性脊柱炎(AS)是一种炎症性自身免疫性疾病。AS 是脊柱关节病(SpA)的典型形式。AS 的确切病因尚未完全了解。但是炎症在疾病发病机制中起着关键作用。免疫系统由各种细胞、分泌介质和标志物来管理和调节免疫反应和炎症。任何扰乱这种调节和止血的因素都可能导致慢性炎症。在这篇综述中,我们讨论了几种先天和适应性免疫细胞在 AS 的触发、启动、发展和调节中的作用。

相似文献

1
Immune cells involved in the pathogenesis of ankylosing spondylitis.参与强直性脊柱炎发病机制的免疫细胞。
Biomed Pharmacother. 2018 Apr;100:198-204. doi: 10.1016/j.biopha.2018.01.108. Epub 2018 Feb 16.
2
Subclinical gut inflammation in ankylosing spondylitis.强直性脊柱炎中的亚临床肠道炎症
Curr Opin Rheumatol. 2016 Jan;28(1):89-96. doi: 10.1097/BOR.0000000000000239.
3
[Pathogenesis of ankylosing spondylitis-mechanisms of disease manifestation and chronicity].[强直性脊柱炎的发病机制——疾病表现及慢性化机制]
Z Rheumatol. 2004 Jun;63(3):187-92. doi: 10.1007/s00393-004-0628-x.
4
Ankylosing spondylitis: an autoimmune or autoinflammatory disease?强直性脊柱炎:一种自身免疫性疾病还是自身炎症性疾病?
Nat Rev Rheumatol. 2021 Jul;17(7):387-404. doi: 10.1038/s41584-021-00625-y. Epub 2021 Jun 10.
5
The role of innate lymphoid cells in health and disease.固有淋巴细胞在健康和疾病中的作用。
J Cell Physiol. 2018 Jun;233(6):4512-4529. doi: 10.1002/jcp.26250. Epub 2018 Jan 15.
6
Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity.某些自身免疫性疾病的免疫调节:巨噬细胞和中性粒细胞在固有免疫和适应性免疫中的关键作用。
J Transl Med. 2017 Feb 15;15(1):36. doi: 10.1186/s12967-017-1141-8.
7
Increased expression of T cell immunoglobulin and mucin domain 4 is positively associated with the disease severity of patients with ankylosing spondylitis.T 细胞免疫球蛋白和黏蛋白结构域 4 的表达增加与强直性脊柱炎患者的疾病严重程度呈正相关。
Inflammation. 2015;38(3):935-40. doi: 10.1007/s10753-014-0055-3.
8
Beta2-microglobulin as a potential initiator of inflammatory responses.β2微球蛋白作为炎症反应的潜在引发剂。
Trends Immunol. 2003 May;24(5):228-9; author reply 229-30. doi: 10.1016/s1471-4906(03)00076-0.
9
Update on ankylosing spondylitis: current concepts in pathogenesis.强直性脊柱炎最新进展:发病机制的当前概念
Curr Allergy Asthma Rep. 2015 Jan;15(1):489. doi: 10.1007/s11882-014-0489-6.
10
Genetic association of ankylosing spondylitis with TBX21 influences T-bet and pro-inflammatory cytokine expression in humans and SKG mice as a model of spondyloarthritis.强直性脊柱炎与 TBX21 的遗传关联影响人类和 SKG 小鼠中的 T 细胞转录因子和促炎细胞因子表达,SKG 小鼠是一种脊柱关节炎模型。
Ann Rheum Dis. 2017 Jan;76(1):261-269. doi: 10.1136/annrheumdis-2015-208677. Epub 2016 Apr 28.

引用本文的文献

1
Gut microbiota and ankylosing spondylitis: current insights and future challenges.肠道微生物群与强直性脊柱炎:当前见解与未来挑战。
Microb Cell. 2025 Aug 25;12:210-230. doi: 10.15698/mic2025.08.857. eCollection 2025.
2
Investigating the potential impact of gut microbiota and immune cells on ankylosing spondylitis based on single-cell sequencing and genetic variation analysis.基于单细胞测序和基因变异分析探究肠道微生物群和免疫细胞对强直性脊柱炎的潜在影响。
Clin Rheumatol. 2025 Aug 18. doi: 10.1007/s10067-025-07595-6.
3
New insights into the role of cellular senescence and rheumatic diseases.
细胞衰老与风湿性疾病作用的新见解。
Front Immunol. 2025 May 16;16:1557402. doi: 10.3389/fimmu.2025.1557402. eCollection 2025.
4
Expression of Tim-3 on neutrophils as a novel indicator to assess disease activity and severity in ankylosing spondylitis.中性粒细胞上Tim-3的表达作为评估强直性脊柱炎疾病活动度和严重程度的新指标
Front Med (Lausanne). 2025 Mar 13;12:1530077. doi: 10.3389/fmed.2025.1530077. eCollection 2025.
5
Investigating ferroptosis-related genes NFE2L2 in neutrophils for ankylosing spondylitis: therapeutic potential of cassia twigs.研究强直性脊柱炎中性粒细胞中与铁死亡相关的基因NFE2L2:桂枝的治疗潜力
Sci Rep. 2025 Mar 10;15(1):8233. doi: 10.1038/s41598-025-88775-x.
6
Influence of TNF-α Inhibitors on Gut Microbiota and Immune Modulation in Treating Ankylosing Spondylitis: Insights into Therapeutic Mechanisms and Clinical Implications.肿瘤坏死因子-α抑制剂对强直性脊柱炎治疗中肠道微生物群及免疫调节的影响:对治疗机制和临床意义的见解
J Inflamm Res. 2024 Dec 27;17:11741-11752. doi: 10.2147/JIR.S496991. eCollection 2024.
7
Investigating the causal relationship between immune factors and ankylosing spondylitis: insights from a Mendelian Randomization study.探究免疫因素与强直性脊柱炎之间的因果关系:孟德尔随机化研究的见解
Adv Rheumatol. 2024 Dec 18;64(1):89. doi: 10.1186/s42358-024-00428-1.
8
The harmful effect of ankylosing spondylitis on diabetes mellitus: new evidence from the Mendelian randomization analysis.强直性脊柱炎对糖尿病的有害影响:孟德尔随机化分析的新证据。
Front Endocrinol (Lausanne). 2024 Nov 22;15:1369466. doi: 10.3389/fendo.2024.1369466. eCollection 2024.
9
Identification of necroptosis-related genes in ankylosing spondylitis by bioinformatics and experimental validation.生物信息学和实验验证鉴定强直性脊柱炎中的坏死性凋亡相关基因。
J Cell Mol Med. 2024 Jul;28(14):e18557. doi: 10.1111/jcmm.18557.
10
Therapeutic potential of single-nucleotide polymorphism-mediated IL6R inhibitors in ankylosing spondylitis treatment.单核苷酸多态性介导的IL6R抑制剂在强直性脊柱炎治疗中的治疗潜力。
Front Med (Lausanne). 2024 May 21;11:1368346. doi: 10.3389/fmed.2024.1368346. eCollection 2024.